Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: In vitro and in cancer patients

Jing Li, Julie Brahmer, Wells Messersmith, Manuel Hidalgo, Sharyn D. Baker

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: In vitro and in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences